{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:07:51Z","timestamp":1773281271700,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,10,27]],"date-time":"2009-10-27T00:00:00Z","timestamp":1256601600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00198-009-1048-1","type":"journal-article","created":{"date-parts":[[2009,10,26]],"date-time":"2009-10-26T09:39:16Z","timestamp":1256549956000},"page":"1057-1058","source":"Crossref","is-referenced-by-count":29,"title":["Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis"],"prefix":"10.1007","volume":"21","author":[{"given":"F.","family":"Procianoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Procianoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,27]]},"reference":[{"issue":"12","key":"1048_CR1","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM200303203481225","volume":"348","author":"FW Fraunfelder","year":"2003","unstructured":"Fraunfelder FW, Fraunfelder FT (2003) Bisphosphonates and ocular inflammation. N Engl J Med 348(12):1187\u20131188","journal-title":"N Engl J Med"},{"issue":"26","key":"1048_CR2","first-page":"1445","volume":"151","author":"PP Geusens","year":"2007","unstructured":"Geusens PP, Lems WF (2007) Fracture prevention in postmenopausal women with osteoporosis by an annual infusion of zoledronic acid. Ned Tijdschr Geneeskd 151(26):1445\u20131448","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"2","key":"1048_CR3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12032-007-9006-2","volume":"25","author":"S Kilickap","year":"2008","unstructured":"Kilickap S et al (2008) A case report: zoledronic acid-induced anterior uveitis. Med Oncol 25(2):238\u2013240","journal-title":"Med Oncol"},{"issue":"7","key":"1048_CR4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.clon.2006.04.013","volume":"18","author":"TC Woo","year":"2006","unstructured":"Woo TC, Joseph DJ, Wilkinson R (2006) Serious ocular complications of zoledronate. Clin Oncol (R Coll Radiol) 18(7):545\u2013546","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"8","key":"1048_CR5","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/rheumatology\/40.8.956","volume":"40","author":"PJ Ryan","year":"2001","unstructured":"Ryan PJ, Sampath R (2001) Idiopathic orbital inflammation following intravenous pamidronate. Rheumatology (Oxford) 40(8):956\u2013957","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"1048_CR6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/archopht.121.9.1335","volume":"121","author":"PS Subramanian","year":"2003","unstructured":"Subramanian PS et al (2003) Orbital inflammatory disease after pamidronate treatment for metastatic prostate cancer. Arch Ophthalmol 121(9):1335\u20131336","journal-title":"Arch Ophthalmol"},{"issue":"13","key":"1048_CR7","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMc0803366","volume":"359","author":"NS Sharma","year":"2008","unstructured":"Sharma NS et al (2008) Zoledronic acid infusion and orbital inflammatory disease. N Engl J Med 359(13):1410\u20131411","journal-title":"N Engl J Med"},{"issue":"1","key":"1048_CR8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archophthalmol.2007.17","volume":"126","author":"PM Phillips","year":"2008","unstructured":"Phillips PM, Newman SA (2008) Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal cell carcinoma. Arch Ophthalmol 126(1):137\u2013139","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"1048_CR9","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1089\/thy.2007.0405","volume":"18","author":"AG Gianoukakis","year":"2008","unstructured":"Gianoukakis AG, Khadavi N, Smith TJ (2008) Cytokines, Graves\u2019 disease, and thyroid-associated ophthalmopathy. Thyroid 18(9):953\u2013958","journal-title":"Thyroid"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-009-1048-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-009-1048-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-009-1048-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T19:01:06Z","timestamp":1558638066000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-009-1048-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,27]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["1048"],"URL":"https:\/\/doi.org\/10.1007\/s00198-009-1048-1","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,27]]}}}